India Nephrologist Market Poised for Continued Growth—Projected to Reach worth USD 102.7 Million in 2027
Published | 30 June 2021
A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the India Nephrologist market was worth USD 93.6 million in 2020 and is further projected to reach USD 102.7 million by 2027, at a CAGR of 1.4% during the forecast period (2021-2027). In India, the prevalence of kidney diseases is increasing despite major advances in medicine, which leads to an increase in the need for nephrologists. Additionally, technological advancements in the medical field have also positively impacted the growth of the India nephrologist market. Moreover, a cost-effective nephrology system further drives the growth of the India nephrologist market. What’s more, increasing government initiatives to open free dialysis centers for people have further boosted the market growth of India nephrologist market.
Increasing Prevalence of Renal Ailments Driving the Growth of India Nephrologist Market
According to health experts, the number of Indians suffering from chronic kidney disease has more than doubled in the last 15 years, with 17 out of every 100 residents now suffering from some sort of renal illness. The increasing number of geriatric populations in India in the last few years have also propelled the growth of the Indian nephrologist market. The geriatric population is more prone to diseases due to their weak immunity. Dialysis is the most common medical treatment for chronic renal failure in the elderly population. According to the American Society of Nephrology (ASN) every year, India sees a total of 2, 00,000 new dialysis patients. The majority of chronic kidney failure patients are diagnosed in the late stages, with over half of them seeing a nephrologist for the first time in this stage. The AN also states that, in a year, 6000 people undergo a kidney transplant, and 60,000 people get hemodialysis. Thus, the increasing incidences of kidney diseases among the elderly population are driving the growth of the India nephrologist market.
The emergence of better and advanced technologies in the nephrology market has shifted consumer understanding on leveraging these medical facilities for better health benefits, thereby, boosting the demand for nephrologists in India.
Increasing Number of Regulatory Approvals Fueling the Growth of India Nephrologist Market
A pharmaceutical or biotechnology company must first seek approval from regulatory bodies before launching a new product. Among the renowned regulatory bodies in India are the Indian Medical Association and the governing bodies in the nephrology industry. Recent developments in emerging technologies, combined with expertise in the field of medical devices, have led to the introduction of medical devices and drugs for nephrology that has been approved by the regulatory bodies. Thus, nephrologists in India can use new medical devices for checkups and treatment of patients, which in turn is boosting the growth of the India nephrology market. Due to the above-mentioned factors, the India nephrologist market is catching pace.
For instance, J.B. Chemicals & Pharmaceuticals, one of the leading pharmaceutical companies in India has announced its entry into the field of nephrology with the establishment of a new specialized branch called "RENOVA," which will serve patients undergoing treatment for Chronic Kidney Disease. A growing number of cases of hypertension are contributing to the prevalence of CKD in India. As a result, the regulatory bodies are focusing on making sure that the best and most effective drugs are approved for launch in the Indian market, thus accelerating market growth
Diabetes Segment Holds the Largest Share in the Market by Application
Based on applications, the India nephrologist market has been segmented into acute & chronic kidney diseases, kidney-related metabolic disorders, diabetes, fluid, & electrolyte disorders, kidney & pancreas transplantation, glomerulonephritis & glomerular diseases, kidney stones, and others. The diabetes segment held the largest share in the India nephrologist market share in 2020 and is expected to grow at a significant CAGR during the forecast period. A majority of the Indians tend to prefer sweet dishes, which in turn puts them at greater risk of developing diabetes.
In the past few years, the number of people suffering from diabetes has increased due to changes in lifestyles and increased sugar consumption. A diabetic patient from India accounts for one in six worldwide. According to the International Diabetes Federation, as of 2019, there are an estimated 77 million diabetics in India, placing it second among the top ten diabetes-prone countries. Diabetes causes many people to have kidney issues, which is called chronic kidney disease. Therefore, diabetes, a leading cause of chronic kidney disease, drives the growth of the India nephrologist market.
Impact of COVID-19
The pace of the Indian nephrology market has slowed since the COVID-19 pandemic. Due to a shift in the focus of the healthcare sector, primarily towards COVID- related cases, many surgeries, tests, treatment procedures, and appointments related to nephrological disorders have either been cancelled, postponed, or reduced. However, despite irregularities in healthcare regarding chronic disease cases, the nephrology market has not completely collapsed in India.
A patient suffering from chronic kidney diseases requires as many as five dialysis sessions per week. Thus, the nephrology market remained in demand even after many health centers had ceased dialysis activities. Additionally, studies have shown that 3-9% of Covid-19 patients may develop acute kidney injury, and two-thirds of hospitalized patients exhibited massive protein leaks in urine. These issues are being treated with urgent dialysis or continuous renal replacement therapy. These complications continued to drive the nephrology market despite the pandemic.
India Nephrologist Market: Regional Insights
The India nephrologist market is segmented into four regions—North India, South India, East India, and West India. The Southern part of India accounted for the largest share in India nephrologist market followed by North India. South India nephrologist market is expected to grow at a healthy CAGR during the forecast period as the region offers a lucrative opportunity for India nephrologist market. Tamil Nadu was the first state to perform hemodialysis (HD) in 1960. In August 2020, Chennai Corporation announced free dialysis centers across 15 regions. By implementing this initiative, the corporation intends to shorten the time it takes to travel between home and the hospital. This effort will be a public-private partnership that will cover the costs of equipment, land, and electricity. The institution will be managed by the Tamil Nadu Kidney Research Foundation and it will be a zero-cost model.
Competitive Landscape
The India nephrologist market is highly consolidated with a growing dearth of nephrologist staff throughout India. It is very difficult to find nephrologist staff in India who specialize in performing kidney transplants and related treatments that provide kidney care.
The key players in the India Nephrologist market include Coimbatore Kidney Hospitals, Apollo Hospitals, Kokilaben Ambani Hospital, Fortis Hospital, Gleneagles Global Hospitals India, Medanta–the medicity, Artemis Hospital, Max Healthcare Super Specialty, Kovai Medical Center and Hospitals, Sir H. N. Reliance Foundation Hospital and Research Centre, Sir Ganga Ram Hospital and other prominent players.
There are a total of 3300 hospitals (private/ government/ NGO’s/ nursing homes and other dialysis chains) that provide dialysis in India. Additionally, B. Braun, Davita, and Nephroplus are a few of the chains that operate as sole providers of dialysis services. The key players in the India nephrologist market are equipping themselves with robotic technologies and advanced equipment for augmenting their abilities to perform kidney-related treatments with more precision and provide better nephrologist services across India.
Recent Developments
In November 2020, the Asian Institute of Nephrology & Urology (AINU), a world-class, single-specialty, which is South India’s largest center for renal sciences hospital announced its plan of expanding its presence in Hyderabad by adding a new facility to its existing capacity.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the India nephrologist market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the country’s nephrologist market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: June 2021
Nephrology is the branch of medical science that deals with diagnosing and treating kidney diseases. In simple words, the study of the kidney and its disorders in adults and children is known as nephrology. Nephrologists specialize in the treatment of kidney diseases.
Relevant Press Releases
- Vietnam In Vitro Diagnostics (IVD) Market Size Set to Touch USD 1.9 Billion by 2029
- Global Minimal Residual Disease Testing Market Size More Than Doubles to Reach USD 4 Billion by 2029
- US Anticoagulation Therapy Market to Grow at a CAGR of 7.9% until 2028
- Global Cardiac Resynchronization Therapy Market to Witness Significant Growth in Coming Years – Projected to Reach Worth USD 6.2 Billion in 2027
- Generic Drugs Market to Reach USD 745 Billion by 2028